Targeting α-synuclein for treating Parkinson’s disease: mechanistic and therapeutic considerations

Progressive neuronal cell loss in a small subset of brainstem and mesencephalic nuclei and widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites are neuropathological hallmarks of Parkinson’s disease. Most cases occur sporadically, but mutations in several ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Neurol
Main Authors: Dehay, Benjamin, Bourdenx, Mathieu, Gorry, Philippe, Przedborski, Serge, Vila, Miquel, Hunot, Stephane, Singleton, Andrew, Olanow, C. Warren, Merchant, Kalpana M., Bezard, Erwan, Petsko, Gregory A., Meissner, Wassilios G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217462/
https://ncbi.nlm.nih.gov/pubmed/26050140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(15)00006-X
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados